Summary
Updated Aug 31, 2026
Eric Weisblum is Chief Executive Officer, Director of Silo Pharma, Inc. (SILO). 5 SEC Form 4 filings on record going back to 2024, most recently on 16 December 2025. Most recent open-market trade: bought $1K of SILO on 16 December 2025. Lifetime open-market purchases: $14K. Historical track record: 3/5 stars across 9 tracked purchases.
Recent Transactions
9Every recent SEC Form 4 transaction Eric Weisblum has reported, most recent first.
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★★★☆☆ (3/5) |
| Total purchases tracked | 9 |
| Purchases with forward-return data | 9 |
| 30-day win rate | 44% |
| 90-day win rate | 33% |
| Avg 5-day return | +5.83% |
| Avg 30-day return | +12.50% |
| Avg 90-day return | +6.11% |
| Best 30-day return | +105.96% |
Trading Pattern
InsiderAlpha's records for Eric Weisblum go back to 2024: 5 primary Form 4 filings, an average of 1.7 per year. The typical open-market purchase is $2K (9 buys totaling $14K). The largest single buy on record is $3K of SILO in 2025. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Most Active Insiders Right Now
Eric Weisblum has no co-filers on record, so these are insiders with the largest open-market activity across the market in the last 90 days.
- Blackstone Holdings II L.P. - $705.06M of JMKE open-market activity in the last 90 days
- Submarine Buyer LLC - $705.06M of JMKE open-market activity in the last 90 days
- CASCADE INVESTMENT, L.L.C. - $685.25M of RSG open-market activity in the last 90 days
- BDT CAPITAL PARTNERS, LLC - $589.61M of ALH open-market activity in the last 90 days
- Joseph Gebbia - $510.90M of ABNB open-market activity in the last 90 days
- ORCP III DE TopCo GP, LLC - $497.40M of PRMB open-market activity in the last 90 days
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Eric Weisblum?
Eric Weisblum is a corporate insider, tracked as Chief Executive Officer, Director of Silo Pharma, Inc. (SILO). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Eric Weisblum last file a Form 4?
The most recent primary Form 4 on record is dated 16 December 2025, one of 5 filings going back to 2024.
Has Eric Weisblum been buying or selling stock?
Recorded transactions: 9 open-market purchases ($14K) and 0 open-market sales across all tracked filings.
How accurate is Eric Weisblum's historical track record?
Across 9 tracked purchases, Eric Weisblum averaged +12.5% avg 30-day return with a 44% 30-day win rate. InsiderAlpha rates the track record at 3/5 stars.
Where can I see all of Eric Weisblum's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Eric Weisblum and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial